21 May 2013
Keywords: novo, insulin, analog, launched, usa, denmark, nordisk
Article | 19 September 2001
Denmark's Novo Nordisk has launched a new rapid-acting insulin analog,NovoLog (insulin aspart), in the USA for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 2001
18 September 2001
20 May 2013
© 2013 thepharmaletter.com